Who are Supernus Pharmaceuticals's investors?

Supernus Pharmaceuticals's investors include New Enterprise Associates (NEA).

How much funding has Supernus Pharmaceuticals raised?

Supernus Pharmaceuticals has disclosed $30M raised across 1 round.

Where is Supernus Pharmaceuticals headquartered?

Supernus Pharmaceuticals is headquartered in Rockville, US.

Supernus Pharmaceuticals

Rockville, US · Founded 2005 · 857 employees on LinkedIn · 1 known investors

Supernus is a pharmaceutical company that develops and markets products in the biosciences and pharmaceutical industry. This page lists awards and recognitions the company has received for growth, workplace, and performance.

Biotech Healthtech

Founders & leadership

John M. SiebertNamed on SEC filing

Michael BighamNamed on SEC filing

William A. NuergeNamed on SEC filing

Michael B. Sheffery, Ph.D.Named on SEC filing

Padmanabh P. Bhatt, Ph.D.Named on SEC filing

Charles W. Newhall, IIINamed on SEC filing

M. James Barrett, Ph.D.Named on SEC filing

Paolo Baroldi, M.D., Ph.D.Named on SEC filing

Frederick M. HudsonNamed on SEC filing

Jack A. KhattarNamed on SEC filing

Tami T. Martin, R.N., Esq.Named on SEC filing

Russell P. WilsonNamed on SEC filing

Investors · 1

New Enterprise Associates (NEA)Menlo Park · $200K – $40M

Reported raises · per SEC filings

Form D private placements

$30M disclosed across 1 round · 2011

▶$30MraisedFeb 2012 · 3 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

John M. SiebertDirector
Michael BighamDirector
William A. NuergeDirector
Michael B. Sheffery, Ph.D.Director
Padmanabh P. Bhatt, Ph.D.Executive Officer
Charles W. Newhall, IIIDirector
M. James Barrett, Ph.D.Director
Paolo Baroldi, M.D., Ph.D.Executive Officer
Frederick M. HudsonDirector
Jack A. KhattarExecutive Officer, Director
Tami T. Martin, R.N., Esq.Executive Officer
Russell P. WilsonExecutive Officer
Jones W. Bryan, Ph.D.Executive Officer

Offering amount: $30M
Amount sold: $30M
Minimum investment: $2M
First sale: Jan 2011
Incorporated: Corporation, Delaware
Federal exemptions: 06

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Supernus Pharmaceuticals do?: Supernus is a pharmaceutical company that develops and markets products in the biosciences and pharmaceutical industry. This page lists awards and recognitions the company has received for growth, workplace, and performance.
Who are Supernus Pharmaceuticals's investors?: Supernus Pharmaceuticals's investors include New Enterprise Associates (NEA).
How much funding has Supernus Pharmaceuticals raised?: Supernus Pharmaceuticals has disclosed $30M raised across 1 round.
Where is Supernus Pharmaceuticals headquartered?: Supernus Pharmaceuticals is headquartered in Rockville, US.